CEP70 and neoplasm: BiTE is a relatively mature kind of BsAb obtained by ligating anti-CD3 single-chain Fv (scFv) with its counterpart of various anti-tumor cell surface antigens through peptides, which can simultaneously bind T cells to tumor cells and induce continuous attack of the target without T-cell apoptosis or anergy.